AQW 29436/22-27
Mr David Honeyford
Alliance Party
Lagan Valley
Tabled Date: 27/06/2025
Answered On Date: 22/07/2025
Priority Written: No
Question:
To ask the Minister of Finance to detail the amount received by the Executive in Barnett Consequentials arising from uplifts to Research and Development spending in England announced by the UK Government, in each of the last five financial years.
Answer:
The Executive received £14.833 million of net Barnett consequentials arising from changes to Research and Development spending in England in the last five financial years. This includes increased consequentials of £17.263 million from spending uplifts and reduced consequentials of £2.430 million from spending reductions. The Executive also received Barnett consequentials from previous Spending Reviews. However, as these are based on departmental outcomes and are not broken down by individual measure, we cannot identify the detail of the Barnett consequentials received. Barnett consequentials are unhypothecated. As such, it is a matter for the Executive to agree how this funding will be allocated considering all competing priorities. The following table sets out the Research and Development related consequential received outside of Spending Reviews. Fiscal Event | Budget Type | Measure | 2020-21 | 2021-22 | 2022-23 | 2023-24 | 2024-25 | Autumn Statement 2016 | CDEL | Quality-related Research funding | 2.775 | - | - | - | - | Budget 2020 | CDEL | Covid-19 R&D | 0.983 | - | - | - | - | Budget 2020 | CDEL | Funding 'excellent' research, across all regions and nations of UK | 12.684 | - | - | - | - | Budget 2020 | CDEL | NIHR- Prevention and translational research | 0.393 | - | - | - | - | Supplementary Estimates 2020-21 | CDEL | ODA- Global Challenges Research Fund (GCRF) | -0.171 | - | - | - | - | Supplementary Estimates 2020-21 | CDEL | NHM Research Facility | -0.015 | - | - | - | - | Supplementary Estimates 2021-22 | CDEL | National History Museum Research Facility | - | -0.077 | - | - | - | Supplementary Estimates 2021-22 | CDEL | Research & Development Capital surrender | - | -0.066 | - | - | - | Supplementary Estimates 2021-22 | CDEL | Vaccine R&D | - | -0.022 | - | - | - | Supplementary Estimates 2022-23 | CDEL | R&D | - | - | -0.005 | - | - | Supplementary Estimates 2022-23 | CDEL | NHM Research Facility | - | - | -0.262 | - | - | Supplementary Estimates 2022-23 | CDEL | Ring-fence Hand backs: CDEL: Research and Development | - | - | -0.040 | - | - | Supplementary Estimates 2022-23 | RDEL | Shared Outcomes Fund: research on Covid-19 impacts | - | - | -0.008 | - | - | Spring Supps 2023-24 | CDEL | R&D | - | - | - | -0.005 | - | Spring Supps 2023-24 | CDEL | R&D- NHM unlocked | - | - | - | -0.638 | - | Spring Supps 2023-24 | CDEL | Research Venture Catalyst underspend | - | - | - | -0.010 | - | Mains 2024-25 | CDEL | R&D- NHM Unlocked | - | - | - | - | -0.868 | Autumn Budget 2024 | RDEL | Research | - | - | - | - | 0.212 | Autumn Budget 2024 | RDEL | PRS Research & Reviews | - | - | - | - | 0.216 | Spring Supps 2024-25 | CDEL | NHM Research Facility | - | - | - | - | -0.244 | Total | | | 16.649 | -0.165 | -0.314 | -0.653 | -0.685 |
|